Product Information
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.1322 per EA under NDC 00093500356. Its NADAC has been published 488 times since Apr 19, 2017.
FDA first approved this application on Nov 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5
Olmesartan Medoxomil, Amlodipine and HydrochlorothiazideStrength
10; 12.5; 40 mg/1; mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093500356
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA202491FDA Approved
11/3/2016
TE Code
AB
On Market Since
11/14/2016
Pharmacological Classes
Price Statistics
The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has been published 488 times since Apr 19, 2017, and over the history we have for it it has declined 63.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1322 per EA |
|---|---|
| All-time high | $3.2964 (Jul 12, 2017) |
| All-time low | $1.0705 (Sep 20, 2023) |
| 52-week high | $1.6099 |
| 52-week low | $1.1322 |
| Median price | $1.7359 |
| Average price | $1.8067 |
| Largest weekly change | +34.6% (Sep 19, 2018) |
| Weeks tracked | 488 |
| Tracking since | Apr 19, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, manufactured by Teva Pharmaceuticals USA Inc., is $1.1322 per EA (NDC 00093500356), effective Aug 19, 2026.
How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 changed over time?
Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has declined 63.5%. It has been tracked across 488 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
Since Apr 19, 2017, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has ranged from a low of $1.0705 (Sep 20, 2023) to a high of $3.2964 (Jul 12, 2017), with a median of $1.7359 per EA.
Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
No other NADAC-published product currently shares the active ingredient and strength of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 (NDC 00093500356) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.